New Key Statistics Module, Z-Score and F-Score
SZSE:301230 Key Ratios
Market Cap ¥ M | 3,570.63 |
Enterprise Value ¥ M | 3,396.56 |
P/E(ttm) | 501.57 |
PE Ratio without NRI | 1,023.20 |
Forward PE Ratio | 30.76 |
Price/Book | 3.42 |
Price/Sales | 6.87 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 13.20 |
Revenue (TTM) ¥ M | 513.00 |
EPS (TTM) ¥ | 0.05 |
Beneish M-Score | -1.35 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 20.90 |
y-y EBITDA Growth Rate % | -95.90 |
EV-to-EBIT | 884.48 |
EV-to-EBITDA | 884.48 |
PEG | 48.96 |
Shares Outstanding M | 139.59 |
Net Margin (%) | 1.35 |
Operating Margin % | -0.49 |
Pre-tax Margin (%) | -1.12 |
Quick Ratio | 3.60 |
Current Ratio | 4.12 |
ROA % (ttm) | 0.48 |
ROE % (ttm) | 0.64 |
ROIC % (ttm) | 0.37 |
Dividend Yield % | 1.68 |
Altman Z-Score | 8.36 |
SZSE:301230 Number of Guru Trades
SZSE:301230 Volume of Guru Trades
Gurus Latest Trades with SZSE:301230
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301230 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pharma Resources (Shanghai) Co Ltd Insider Transactions
No Available Data